US-based Moderna Therapeutics has announced the completion of a new financing round, raising $110m to develop messenger RNA Therapeutics. In aggregate, Moderna has secured more than $415m in financing and partnerships to date from the ...
The US Food and Drug Administration (FDA) has accepted AstraZeneca's new drug application (NDA) for naloxegol, an investigational peripherally-acting mu-opioid receptor antagonist (PAMORA). The drug has been studied in opioid-induced ...
Tags: Drug Application, FDA Approval
Four scientists from top pharmaceutical companies have collaborated to bring together the successful strategies for implementing an electronic patient reported outcome (ePRO) system in the form of an ebook. The handbook named "How to ...
Tags: ePRO Strategy, PHT
Unilife, a US based manufacturer of injectable drug delivery systems, has announced an agreement with MedImmune, the global biologics research and development arm of AstraZeneca, to customize and supply devices from its platform of wearable ...
AstraZeneca has selected an undisclosed oncology target from Regulus Therapeutics as part of their strategic alliance in order to discover, develop and commercialize microRNA therapeutics. Both the companies have entered into a strategic ...
Cannabis Biotech, a subsidiary of Puget Technologies, is introducing product research for a transmucosal delivery system to deliver medical marijuana through the mucous membrane of the nasal cavity. Cannabis Biotech's new project is ...
Tags: Cannabis Biotech
AstraZeneca has partnered with Taiwan’s National Research Program for Biopharmaceuticals (NRPB) in order to support academic research proposals using 'open innovation' as a catalyst for accelerating drug discovery. The project will ...
AstraZeneca's global biologics research and development division MedImmune will acquire Spirogen, a biotech firm focused on antibody-drug conjugate technology for use in oncology. Spirogen's complete shares will be purchased by MedImmune ...
Tags: biologics research, AstraZeneca
US-based biotechnology company X-Chem and UK-based pharmaceutical company AstraZeneca have entered into an expanded global drug discovery collaboration that covers all of AstraZeneca’s therapeutic areas and multiple target classes. ...
Tags: Drug, pharmaceutical
US-biotechnology company Labcyte has partnered with AstraZeneca to develop acoustic sample handling for mass spectrometry to advance drug discovery applications. Biotechnology tools firm Labcyte has recently developed techniques for the ...
Tags: Labcyte Partners
British drugmaker AstraZeneca has received positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for its new four-in-one flu vaccine Fluenz Tetra. Fluenz Tetra, a nasally ...
Tags: Astrazeneca, Medicine
The US Food and Drug Administration (FDA) has accepted to review AstraZeneca's new drug application (NDA) for Epanova, an investigational compound for the treatment for patients with severe hypertriglyceridaemia. Omthera Pharmaceuticals, ...
US-based pharmaceutical manufacturer and marketer Forest Laboratories (FRX) has received qualified infectious disease product (QIDP) designation for its ceftazidime/avibactam drug from the US Food and Drug Administration (FDA). Currently ...
Tags: drug, Forest Laboratories
British drugmaker AstraZeneca and US biotechnology company FibroGen have formed a strategic partnership to develop and commercialize FG-4592 to treat anemia in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). ...
Tags: Anemia Drug, Astrazeneca
Marsh will join DS Smith from Tesco where he was the group director of tax and corporate finance for three and a half years. He was also chief financial officer (CFO) at AstraZeneca and CFO of Global Building Products at Pilkington. ...